{
    "clinical_study": {
        "@rank": "55411", 
        "arm_group": [
            {
                "arm_group_label": "Healthy volunteers"
            }, 
            {
                "arm_group_label": "Chronic hepatitis C"
            }
        ], 
        "biospec_descr": {
            "textblock": "whole blood, serum, plasma,liver biopsies specimens,"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the progression of chronic hepatitis C patients\n      infected by paid plasma donation,and explore the possible pathogenic mechanisms of disease\n      progression in chronic hepatitis C."
        }, 
        "brief_title": "Prospective Observational Study of Disease Progression in Chronic Hepatitis C", 
        "completion_date": {
            "#text": "July 2030", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Hepatitis C, Chronic", 
            "Disease Progression", 
            "Liver Cirrhosis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hepatitis", 
                "Hepatitis A", 
                "Hepatitis, Chronic", 
                "Hepatitis C", 
                "Liver Cirrhosis", 
                "Fibrosis", 
                "Disease Progression", 
                "Hepatitis C, Chronic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All these patients had a definite history of regular plasma donations with repeated\n             blood cell re-transfusions.\n\n          -  The Hepatitis C Virus antibody was positive.\n\n          -  All patients did not receive interferon therapy before being recruited.\n\n        Exclusion Criteria:\n\n          -  Patients with evidences for other forms of liver diseases.\n\n          -  The coinfection with hepatitis B virus or other virus."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "The plasma donors were primarily chosen from healthy farmers and agricultural workers\n        living in a remote small city in the Northwest China."
            }
        }, 
        "enrollment": {
            "#text": "133", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02011932", 
            "org_study_id": "BJYAH-2011-045"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 13, 2013", 
        "number_of_groups": "2", 
        "official_title": "Observational Study of Disease Progression and Risk Factors in Chronic Hepatitis C Caused by Plasma Donation", 
        "overall_official": {
            "affiliation": "Beijing YouAn Hospital, Capital Medical University", 
            "last_name": "Zhongping Duan, Ph.D.,M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "China: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Fibrosis progression rate", 
                "safety_issue": "No", 
                "time_frame": "20 years"
            }, 
            {
                "measure": "The incidence of cirrhosis", 
                "safety_issue": "No", 
                "time_frame": "20 years"
            }, 
            {
                "measure": "Risk factors for the occurrence of cirrhosis", 
                "safety_issue": "No", 
                "time_frame": "20 years"
            }
        ], 
        "reference": [
            {
                "PMID": "12407575", 
                "citation": "Seeff LB. Natural history of chronic hepatitis C. Hepatology. 2002 Nov;36(5 Suppl 1):S35-46. Review."
            }, 
            {
                "PMID": "9121257", 
                "citation": "Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997 Mar 22;349(9055):825-32."
            }, 
            {
                "PMID": "12512034", 
                "citation": "Ghany MG, Kleiner DE, Alter H, Doo E, Khokar F, Promrat K, Herion D, Park Y, Liang TJ, Hoofnagle JH. Progression of fibrosis in chronic hepatitis C. Gastroenterology. 2003 Jan;124(1):97-104."
            }, 
            {
                "PMID": "10644270", 
                "citation": "Seeff LB, Miller RN, Rabkin CS, Buskell-Bales Z, Straley-Eason KD, Smoak BL, Johnson LD, Lee SR, Kaplan EL. 45-year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med. 2000 Jan 18;132(2):105-11."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02011932"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Beijing YouAn Hospital", 
            "investigator_full_name": "Zhongping Duan", 
            "investigator_title": "Associate Dean,Professor,Chief Physician", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "The incidence of hepatocellular carcinoma", 
                "safety_issue": "No", 
                "time_frame": "20 years"
            }, 
            {
                "measure": "Number of participants with chronic hepatitis C-related complications", 
                "safety_issue": "No", 
                "time_frame": "20 years"
            }
        ], 
        "source": "Beijing YouAn Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Beijing YouAn Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2010", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}